Delivery Order SPE2DB20D1100-SPE2DB25FB8C1

Award Date 4/17/25
Potential Completion Date 4/18/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,815.46 firm-fixed-price delivery order contract is for the supply of the HIV medication Biktarvy, with a period of performance through May 14, 2025. The contract is not set aside and was awarded as part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the HIV medication Biktarvy. The contract has a ceiling value of $5,958.02 and a performance period extending through April 11, 2025. This contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $13,656.10 and is a delivery order contract with a firm fixed price pricing type. The contract is for the supply of the drug Biktarvy, a prescription medication used for the treatment of HIV-1 infection. The contract has an ultimate completion date of January 6, 2025. This award is part of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $22,251.52, is for the supply of the prescription medication Biktarvy, a fixed-dose combination tablet used to treat HIV-1 infection. The award is issued under an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $15,481.60 delivery order contract is for the drug Biktarvy, which is used to treat HIV, and has a completion date of December 3, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,567.94 firm fixed-price delivery order is for the supply of the HIV medication Biktarvy 50-200-25 mg tablets. The award has an ultimate completion date of July 29, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $41,322.09 and is a delivery order for the medication Biktarvy, a combination drug used to treat HIV. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed price contract. This contract award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $122,164.60, is for the delivery of the HIV medication Biktarvy 50-200-25 mg tablets. The contract is a firm fixed-price delivery order with a completion date of January 31, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the HIV medication Biktarvy in 30-count tablet packages. The contract, valued at $17,907.06, was awarded by the Defense Logistics Agency (DLA) and does not have a set-aside designation, indicating open competition. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of October 18, 2024. AmerisourceBergen holds a significant...
This federal contract award, valued at $10,626.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and expiring in December 2026. The contract is for the supply of 4,568,062,817 units of the prescription medication Biktarvy, a fixed-dose...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FB8C1
    Delivery Order

This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,919.26, is for the supply of the HIV medication Biktarvy. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set aside and is open to full and open competition. The award supports the DLA's role in supplying a wide range of pharmaceutical products and medical supplies to military healthcare programs and other government agencies.

Generated 7/17/25, 2:20 PM